Haselmeier Launches JuniorSTAR by Sanofi
The new and reusable half-unit insulin pen JuniorSTAR is now available in Germany. It is suitable for all insulin types of Sanofi. It provides individual dosage, which can be corrected easily. Furthermore, it has a large display to ensure the correct dosage and is a lightweight companion during the day, especially for young people with diabetes.
"The launch of JuniorSTAR marks another milestone of a long-term partnership with Sanofi. After the single unit pen TactiPen, the portfolio is now completed by the half-unit pen JuniorSTAR. The JuniorSTAR delivers 1 to 30 units in steps of 0.5. Thanks to the close co-operation of both teams we were able to develop an excellent pen which meets the current very high quality requirements." explains Sandra de Haan, Director Project Management at Haselmeier and responsible project manager for the JuniorSTAR project.
"The JuniorSTAR expands our individual portfolio for people suffering from diabetes. This pen offers, especially young people with type 1 diabetes, a flexible and easy handling to lighten their lives with diabetes. The excellent and close cooperation with Haselmeier was an important part for the successful development of the JuniorSTAR pen," explains Hamit Oualali, Global Device Manager for reusable pens at Sanofi.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance